Close X
Get more out of WDDTY.com
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs
OR

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.


Click here if you're interested
Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!

Children are the new target for drugs
About the author: 
WDDTY Team

Children may soon be targeted by prescription drugs designed specifically for them - and, for once, the move hasn't come directly from the pharmaceutical companies

Children may soon be targeted by prescription drugs designed specifically for them - and, for once, the move hasn't come directly from the pharmaceutical companies.


The European Commission is ostensibly behind the move, and is said to be 'urging' drug companies to develop medicines that are suitable for children under the age of 16.


This would involve tailoring drugs and dosages that first would have to be tested on groups of children before receiving a licence for distribution. Drug companies in the USA have already taken the lead, and have carried out around 400 clinical trials in the last four years that have involved children.


The new drugs would be smaller so that children could swallow them more easily, and the dose would be appropriate, thus avoiding serious errors when adult dosages are adjusted.


Although the pharmaceutical industry is the most profitable sector in the world, the EU still feels it may need a little financial incentive to open up a whole new market, and is suggesting the creation of a special fund to encourage clinical research involving children.


As if that's not enough, the EU is also thinking up other attractions, such as the creation of longer periods of intellectual property protection to reward the companies that develop innovative drugs.


Drug companies have been invited to ponder the EU's largesse before draft legislation is prepared for release in the summer.


The EU might also consider that, as adverse reactions to drugs are now one of the world's major killers, putting our children at such risk may need a little more thought than just how we intend to reward the drug companies (BMJ, 2002; 324: 563).


You may also be interested in...

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2017 WDDTY Publishing Ltd.
All Rights Reserved